News

We are looking for a talented individual to join the SyNergy and SFB/Transregio 274 Genomics-Hub. Position focuses on managing single-cell transcriptome profiling projects on clinically relevant questions. The successful candidate will operate the latest genomic pipeline with cutting edge equipment, develop new protocols and assays, and perform high-quality genomics services for biomedical research and genomic medicine. The position focuses on single-cell genomics, which is a hot topic with high demand in academia and industry, thus creating a highly promising area for future career development.

More information on how to apply can be found here.

We are happy to announce that we will offer the TRR274 lecture series again in the coming winter semester 2022/23. We have recruited new lecturers (from within our TRR274 PIs and members) that will teach you about new topics and more aspects of CNS recovery and the different checkpoints that lead to it. The lectures will take place online over Zoom on Tuesday (bi-weekly) from 5 - 6.30pm.

You will find the schedule, lecturers and topics here. 

Everyone interested in learning about what factors determine the multicellular response following CNS injury is welcome to join. 

Our next TRR274/DZNE/SyNergy seminar will take place on Wednesday 2 March 2022 at 4pm. 

We are pleased to welcome Dororn Merkler, Professor at the University and University Hospitals of Geneva, as our next guest speaker! He will give a talk entitled "Modelling immune responses trapped behind the blood-brain barrier". The seminar will be led by our TRR 274 PI Mikael Simons.

The seminar will take place online via Zoom.

We look forward to seeing you there!

The Institute for Neuroimmunology and Multiple Sclerosis Research in Göttingen is looking for a highly motivated person with a clear commitment to basic research, who would like to carry out a PhD project with us.

A PhD position in the area of in vivo imaging of the rodent nervous system is available in the Misgeld lab at TUM’s Institute of Neuronal Cell Biology. The position is available starting earliest 1.9.2022.

The Misgeld lab at the Institute of Neuronal Cell Biology of Technical University of Munich (TUM) and the German Center for Neurodegenerative Disease (DZNE) develops and uses cutting-edge in vivo imaging and omics tools to study axon homeostasis and degeneration with a focus on neuronal cell biology and axon-glial interactions. We are interested in the mechanisms that establish and maintain axonal health, as well as in the processes that cause axon pathology during neurodegeneration and -inflammation (in diseases such as Amyotrophic lateral sclerosis or spinal cord injury).

As part of our Advanced and Early Clinician Scientist Programmes, we are happy to welcome and support Dr. Mihai Ancau and Dr. Kolja Meier as successful applicants to our TRR274 for the funding year 2022. 

Dr. Kolja Meier, our newest Early Clinician Scientist applicant, is a resident clinician in the Klinik für Kinder- und Jugendmedizin at the University Medical Center Göttingen and will work under supervision of Prof. Jutta Gärtner, while Dr. Mihai Ancau, part of the Advanced Clinician Scientist Programme, works as a resident at the Department of Neurology at Klinikum rechts der Isar in Munich and will work under supervision of Prof. Thomas Misgeld.